Video of Dr Jose Montoya speaking on CFS at Stanford University, California

Dr Jose Montoya – who will be speaking at the Invest in ME International Conference on ME in London on May 20 – is seen discussing CFS and current research on diagnosis and treatment at a conference held at Stanford University’s alumni centre in California on 3 March 2011.

Quote from the lecture:

Hopefully one day, my dream is that our medical community will produce a formal apology to the patients that – not having believed them all these years – they are facing a real illness.

Dr Montoya is associate professor of medicine, infectious diseases, at the Stanford University Medical Center. He has already studied the use of an antiviral drug called valganciclovir – marketed by Roche Pharmaceuticals as Valcyte – on patients with CFS. The ME Association followed the progress of this work closely in 2007 and 2008; at one stage, we met with the managing director of Roche in the UK to offer to help facilitate a UK trial of this drug if the company was minded to widen the scope of the trial beyond the study at Stanford.

The Times’ on Dr Montoya’s valganciclovir/Valcyte testing on patients with CFS, 11 January 2007